DNA Healthcare Solutions is developing innovative diagnostics in all areas of molecular testing. The increasing global prevalence of infectious disease and antibiotic resistance has already become the catalyst for this growth. Infectious diseases are steadily growing, presenting new and mutated pathogen strains yearly, which has significantly challenged our healthcare systems. The growing trend of newly detected pathogens coupled with the global epidemic of antibiotic resistance has raised fear and concern among the CDC and World Health Organization. This has created within DNA Healthcare Solutions major new initiatives, including regional and international telepathology, genomic medicine, diversification of research services, and a maturational shift of our programs to the partnership phase of clinical and research training.